NuCana plc (NCNA)
NASDAQ: NCNA · Real-Time Price · USD
1.270
-0.020 (-1.55%)
At close: Nov 21, 2024, 4:00 PM
1.263
-0.007 (-0.54%)
After-hours: Nov 21, 2024, 5:00 PM EST
NuCana Employees
As of December 31, 2023, NuCana had 28 total employees, including 25 full-time and 3 part-time employees. The number of employees decreased by 3 or -9.68% compared to the previous year.
Employees
28
Change (1Y)
-3
Growth (1Y)
-9.68%
Revenue / Employee
n/a
Profits / Employee
-$1,272,096
Market Cap
2.85M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
CareMax | 1,450 |
iSpecimen | 53 |
Aditxt | 47 |
Matinas BioPharma Holdings | 32 |
Processa Pharmaceuticals | 13 |
InMed Pharmaceuticals | 13 |
Bio-Path Holdings | 10 |
PainReform | 7 |
NCNA News
- 10 days ago - NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel - GlobeNewsWire
- 6 weeks ago - Baillie Gifford's Strategic Acquisition of NuCana PLC Shares - GuruFocus
- 2 months ago - NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States - GlobeNewsWire
- 2 months ago - NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024 - GlobeNewsWire
- 3 months ago - NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study - GlobeNewsWire
- 3 months ago - NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 6 months ago - NuCana to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 6 months ago - NuCana to Present at TD Cowen's 5th Annual Oncology Innovation Summit - GlobeNewsWire